Corticosteroids improve survival in critically ill COVID-19 patients

(University of Pittsburgh) In a tremendous demonstration of global collaboration, clinician-scientists have pooled data from 121 hospitals in eight countries to find that inexpensive, widely available steroids improve the odds that very sick COVID-19 patients will survive the illness. The findings were made through the " Randomized Embedded Multifactorial Adaptive Platform-Community Acquired Pneumonia " (REMAP-CAP) trial and are reported today in JAMA as part of a four-article package. The World Health Organization is updating its COVID-19 treatment guidance as a result.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news